Comparative Performance of a Combined Injectable Contraceptive (50 mg Norethisterone Enanthate Plus 5mg Estradiol Valerate) and a Combined Oral Contraceptive (0.15 mg Levonorgestrel plus 0.03 mg Ethinyl Estradiol) in Adolescents

Journal of Pediatric and Adolescent Gynecology

Volumn 22, Issue 1, 2009, Pages 25-31

  Molina, Ramiro C ^a   Sandoval, Jorge Z ^a   Montero, Adela V ^a   Oyarzún, Pamela G ^a   Molina, Temístocles G ^a   González, Electra A ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Contraception in high risk adolescents; Injectable monthly contraceptive

Indexed keywords

ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; AMENORRHEA; ARTICLE; BREAST TENDERNESS; COCAINE DEPENDENCE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERMENORRHEA; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENTAL DISEASE; OLIGOMENORRHEA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEXUALITY; SIDE EFFECT; SPOTTING; WEIGHT REDUCTION;

ADOLESCENT; AMBULATORY CARE FACILITIES; CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LEVONORGESTREL; MEDICATION ADHERENCE; NORETHINDRONE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 59849107677     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2008.07.010     Document Type: Article

References (30)

1. Nelson M.L., and Quintana S.M. Qualitative clinical research with children and adolescents. J Clin Child Adolesc Psychol 34 (2005) 344
2. Molina R. Anticoncepción en la adolescencia. In: Molina R., Sandoval J., and González E. (Eds). Salud Sexual y Reproductiva en la Adolescencia (2002), Chile, Mediterráneo, Santiago 768-785
3. Morgan Mulchahey K. Practical approaches to prescribing contraception in the office setting. Contraception 16 (2005) 665
4. Tremollieres F. [Effect of hormonal contraception on bone mineral density.]. Gynecol Obstet Fertil 33 (2005) 520
5. Scholes D., Lacroix A.Z., Ichikawa L.E., et al. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Contraception 69 (2004) 99
6. World Health Organization. WHO statement on hormonal contraception and bone health. Contraception 73 (2006) 443
7. Casas L. Confidencialidad de la información médica, derecho a la salud y consentimiento sexual de los adolescentes. Rev Chil Obstet Ginecol Inf Adolesc 2 (2005) 94
8. Canavos G.C. Probabilidades y Estadística: Aplicaciones y Métodos. Editores McGraw-Hill/Interamericana (1988) 333-338 350
9. Siegel S. Estadística No Paramétrica: Aplicada a las ciencias de la conducta. México, Editores Trillas (1970) 130-137
10. Martinez Oliva L. Cáncer y ambiente. Bases epidemiológicas para su investigación y control: Métodos epidemiológicos (1990), Editores Metepec, México 57-59
11. Kessuru E., Etchepareborda J.J., Wikinski R., et al. Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density pattern. Contraception 61 (2000) 317
12. Arabi A., Garnero P., Porcher R., et al. Changes in body composition during postmenopausal hormone therapy: a 2 year prospective study. Hum Reprod 18 (2003) 1747
13. Rubinacci A., Peruzzi E., Modena A.B., et al. Effect of low dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women. Menopause 10 (2003) 241
14. Bunyavejchevin S., and Limpaphayom K.K. The metabolic and bone density effects of continuous combined 17 beta estradiol and norethisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial. J Med Assoc Thai 84 (2001) 45
15. Delmas P.D., Confavreux E., Garnero P., et al. A combination of low doses of 17 beta-estradiol and northisterone acetate prevent bone loss and normalizes bone turnover in postmenopausal women. Osteoporos Int 11 (2000) 177
16. Paoletti A.M., Orru M., Floris S., et al. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Contraception 61 (2000) 259
17. Gomez P.I., Correa J.E., Castañeda A., et al. Estudio abierto multicéntrico del anticonceptivo inyectable mensual. Controversias en Ginecología y Obstetricia 6 (1998) 6
18. Bassol S., Cravioto M.C., Durand M., et al. Mesigyna once-a-month combined injectable contraceptive: experience in Latin America. Contraception 61 (2000) 309
19. Fraser I.S. Vaginal bleeding patterns in women using one-a-month injectable contraceptives. Contraception 49 (1994) 399
20. Bulent Tiras M., Noyan V., Fener N., et al. Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters. Contraception 63 (2001) 151
21. Bortolotti de Mello Jacobucci M.S., Guazzelli C.A., Barbieri M., et al. Bleeding patterns of adolescents using a combination contraceptive injection for 1 year. Contraception 73 (2006) 594
22. Belsey E.M. and Task Force on Long-acting Systemic Agents for Fertility Regulation: Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Adv Contracept 7 (1991) 257
23. Widholm O., and Kantero R.L. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers. Acta Obstet Gynecol Scand Suppl 14 Suppl 14 (1971) 1
24. World Health Organization. Multicenter Study on Menstrual and Ovulatory Patterns in Adolescent Girls. I. A Multicenter Cross-sectional Study of Menarche. World Health Organization Task Force on Adolescent Reproductive Health. J Adolesc Health Care 7 (1986) 229
25. World Health Organization. Multicenter Study on Menstrual and Ovulatory Patterns in Adolescent Girls. II. Longitudinal Study of Menstrual Patterns in the eaRly Postmenarcheal Period, Duration of Bleeding Episodes, and Menstrual Cycles. World Health Organization Task Force on Adolescent Reproductive Health. J Adolesc Health Care 7 (1986) 236
26. Westfall J.M., Main D.S., and Barnard L. Continuation rates among injectable contraceptive users. Fam Plann Perspect 28 (1996) 275
27. Tolley E., Loza S., Kafafi L., et al. The impact of menstrual side effects on contraceptive discontinuation: Findings from a longitudinal study in Cairo. Egypt. Int Fam Plann Persp 31 (2005) 15
28. RamaRao S., Lacuesta M., Costello M., et al. The link between quality of care and contraceptive use. Int Fam Plann Persp 29 (2003) 76
29. Ali M., and Cleland J. Contraceptive discontinuation in six developing countries: a cause-specific analysis. Int Fam Plann Persp 21 (1995) 92
30. Kirby D. The impact of programs to increase contraceptive use among adult women: A review of experimental and quasi-experimental studies. Perspect Sex Reprod Health 40 (2008) 34